Applied to radiation oncology, and specifically to radiotherapy technical comparisons, evidence-based medicine implies methodological and ethical problems.
Overall, the analysis concerning all COP parameters revealed a significant main effect of cognitive status on velocity-based variables, with post hoc comparisons evidencing that SD velocity and AAMV increased with cognitive impairment.
Multiple post hoc comparisons evidenced the "non-gambler marmosets" as showing the highest levels of uncertainty-induced restlessness.
Multiple post hoc comparisons evidenced, on the last 2 sessions (i.e., at p = 17%, 14%), that the "gambler marmosets" were showing the highest levels of persistence.
Lastly, the interaction of Letter targetness × Orientation (F[1,12] = 5, p < 0.04) and relative post-hoc comparisons evidenced a significant target effect for standard (target = 1.84; non-target = 1.3 μV) but not rotated (target = 1.3; non-target = 1.46 μV) strings.
Multiple post hoc comparisons evidenced, on final sessions, a significant difference between "non-gambler marmosets" on one side and "gambler marmosets" as well as "non-gambler rats" on the other hand (at p = 20%, 17 %, 14).
Within populations, significant linkage disequilibrium was identified between a single set of loci for both the Texas (loci QS00984 and QS02499) and Oklahoma (loci QS01386 and QS08928) populations, while three pairwise comparisons evidenced linkage disequilibrium (loci QS00766 and QS01904, QS00984 and QS00562, and QS00984 and QS03297) in the Kansas population.
In this type of comparison, evidence is synthesized from aggregate data arising from randomized, controlled studies.
In comparison, evidence of the impact of DEET on human health is limited and mostly derived from illness surveys and case reports [ 21].
For indirect and/or mixed-treatment comparison evidence, NICE considered additional comparators that PBAC did not, including rituximab, adalimumab, certolizumab, etanercept, and golimumab.
